advertisement
Advances in Therapy 26
Showing records 1 to 25 |
Display all abstracts in Advances in Therapy76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMyers JS
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaKatsanos A
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivRoberti G
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMasood I
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaKonstas AG
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivAgnifili L
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMasood I; Hornbeak DM
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivBerardo F
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaMikropoulos DG
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesBelda JI
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivRiva I
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaQuaranta L
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivFigus M
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesAuffarth G
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaVoudouragkaki IC
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivManni G
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaAthanasopoulos GP
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesJünemann A
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaAthanasopoulos GP
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesGiamporcaro JE
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaAsproudis I
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivQuaranta L
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year OutcomesMartinez-de-la-Casa JM
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical HypotensivOddone F
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative GlaucomaTeus MA
Advances in Therapy 2018; 35: 619-630
Issue 19-3
Change Issue
advertisement